Another indication my vision to reconfigure and reform the deadly state of conventional health care in America is a bit closer to becoming a reality: A new PricewaterhouseCoopers report citing a declining trust in the reputation of the mega-pharmaceuticals.
Just to demonstrate how opinions among consumers and various industry industry stakeholders (doctors, researchers, health insurers and policymakers) regarding the mega-pharmaceuticals have soured so dramatically, only the reputation of the oil industry fell more steeply in the eyes of the public.
Among the study's lowlights, that is, for drug companies:
- More than 60 percent of industry stakeholders believe drug companies manipulate or suppress negative clinical trials to maximize sales.
- Almost all the consumers surveyed (94 percent) and most stakeholders (81 percent) feel drug companies promote their toxic products far too aggressive when it comes to unapproved uses.
- Although a vast majority of industry stakeholders fool themselves into believing a patient's health needs come first, consumer opinions are nearly evenly split between need (55 percent) and developing newer and not-any-better drugs or "lifestyle" concoctions with better sales potential.
Keep up the good work, folks. But, please be aware, the battle is merely beginning...
Outsourcing-Pharma.com January 11, 2007DrugNewswire.com January 10, 2007